The 8-Aminopurine Hypothesis
8-氨基嘌呤假说
基本信息
- 批准号:10650178
- 负责人:
- 金额:$ 50.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:2-AminopurineAnabolismAnimalsAntihypertensive AgentsBiochemicalBiologicalBlood PressureBrain InjuriesCardiovascular DiseasesCessation of lifeChemical StructureCirculationDahl Hypertensive RatsDeoxycorticosteroneDietDiureticsExcess Dietary SaltExcretory functionFundingHeartHypertensionHypoxanthinesInbred SHR RatsInosineKidneyLongevityMediatingMetabolic syndromeMetabolismModelingOralOral AdministrationOrganPreventionPublishingPurine-Nucleoside PhosphorylaseRattusRenal functionSodium ChlorideStrokeSystemTestingWorkXanthine Oxidaseanalogblood pressure reductiondietary saltexperimental studyhigh salt diethypertensiveimprovedin vivoinhibitorinterstitialmortalitypharmacologicprematurepreventprotective effectsalt intakesalt sensitive hypertensionsaluretictranslational potential
项目摘要
We have discovered that 8-aminoguanine (8A-Guanine), a naturally-occurring 8-aminopurine, has a unique
pharmacological profile, i.e., it exerts diuretic, natriuretic, glucosuric, antikaluretic and antihypertensive activity.
In addition, 8A-Guanine protects against target-organ damage and increases the lifespan of Dahl SS rats on a
high salt diet, an effect due to prevention of salt-induced strokes. Because 8-aminoguanosine (8A-
Guanosine) is converted to 8A-Guanine in the systemic circulation, this 8-aminopurine has similar effects to
8A-Guanine. The mechanism of action of 8A-Guanine (and 8A-Guanosine via its metabolism to 8A-Guanine) is
mostly via inhibition of purine nucleoside phosphorylase (PNPase). Importantly, in preliminary experiments we
observed that in Dahl SS rats a high salt diet (4%) reduced endogenous renal interstitial levels of 8A-
Guanosine and 8A-Guanine by 85% and 100%, respectively. These preliminary studies suggest that a high
salt intake induces 8-aminopurine deficiency, at least in Dahl SS rats; but this finding must be confirmed in
Dahl SS rats and tested in other models of hypertension. It occurred to us that 8-aminoinosine (8A-Ino) and
8-aminohypoxanthine (8A-HX) have chemical structures very similar to 8A-Guanosine and 8A-Guanine,
respectively, and are analogues of naturally-occurring inosine and hypoxanthine, respectively; therefore we
reasoned that these compounds too may be endogenous 8-aminopurines with beneficial biological activities.
Because no one has ever examined the biological effects of either 8A-Ino or 8A-HX, we conducted preliminary
renal studies with these compounds. These preliminary studies suggest that both 8A-Ino and 8A-HX may have
effects on renal function similar to those of 8A-Guanosine and 8A-Guanine, but may be even more efficacious
in this regard. However, these findings must be confirmed. Also, it is unknown: 1) whether the effects of 8A-Ino
are mediated via its metabolism to 8A-HX; 2) whether 8A-Ino and 8A-HX have antihypertensive and organ-
protective effects; 3) whether 8A-Ino and 8A-HX, like 8A-Guanosine and 8A-Guanine, are naturally-occurring;
and 4) whether their biosynthesis is also suppressed by a high salt diet. Together, our published and
preliminary findings motivate our “8-AMINOPURINE HYPOTHESIS”, which postulates that: 1) 8A-Guanosine,
8A-Guanine, 8A-Ino and 8A-HX comprise a naturally-occurring 8-aminopurine system that is
natriuretic, antihypertensive and organ-protective; 2) 8-aminopurine deficiency contributes to salt-
sensitive hypertension, target-organ damage and mortality; and 3) 8-aminopurine deficiency can be
corrected by oral treatment with 8-aminopurines. Here we propose to further test this hypothesis by: 1)
elucidating the renal effects of 8A-Ino and 8A-HX; 2) determining whether a high salt diet induces a deficiency
in all 4 8-aminopurines; and 3) determining whether 8A-Ino and 8A-HX, like 8A-Guanosine and 8A-Guanine,
have antihypertensive activity and prevent target organ damage. Finally, we will explore whether the
mechanism of action of 8A-Ino and 8A-HX involves not only inhibition of PNPase, but also of xanthine oxidase.
我们发现8-氨基瓜氨酸(8a-瓜氨酸)是一种天然的8-氨基嘌呤,具有独特的
药理学特征,即,它导出利尿剂,脂肪尿剂,葡萄糖尿疗法,抗红血药和降压活性。
此外,8A-瓜氨酸可以防止目标器官损害,并增加了Dahl SS大鼠的寿命
高盐饮食,由于预防盐引起的中风而产生的作用。因为8-aminoguanosine(8a--
在全身循环中,鸟嘌呤被转化为8a-瓜氨酸,这种8-氨基嘌呤的作用与
8a-瓜氨酸。 8a-瓜氨酸的作用机理(和8A-瓜氨酸通过其代谢为8a-瓜氨酸)是
主要是通过抑制嘌呤核磷酸化酶(PNPase)。重要的是,在初步实验中
观察到,在达尔SS中,高盐饮食(4%)降低了8a-的内源性肾脏间质水平
鸟嘌呤和8A-瓜氨酸分别为85%和100%。这些初步研究表明
盐摄入至少在DAHL SS大鼠中诱导8-氨基尿素缺乏症;但是这一发现必须在
DAHL SS大鼠并在其他高血压模型中进行了测试。我们发生了8-氨基氨氨酸(8a-ino)和
8-氨基黄嘌呤(8A-HX)的化学结构非常类似于8a-瓜氨酸和8A-瓜氨酸,
分别是天然肌苷和甲黄嘌呤的类似物。因此我们
有理由认为这些化合物也可能是具有有益的生物学活性的内源性8-氨基尿素。
因为没有人检查过8A-ino或8a-hx的生物学效应,所以我们进行了初步
这些化合物的肾脏研究。这些初步研究表明,8a-ino和8a-hx可能具有
对肾功能的影响类似于8A-瓜氨酸和8A-瓜氨酸的影响,但可能更有效
在这方面。但是,必须确认这些发现。另外,这是未知的:1)8a-ino的影响是否
通过其代谢介导至8A-HX; 2)8a-ino和8a-hx是否具有降压和器官
保护作用; 3)8a-ino和8a-hx(例如8a-瓜氨酸和8a-瓜氨酸)是否自然存在;
4)高盐饮食是否也抑制了它们的生物合成。一起,我们出版了
初步发现激发了我们的“ 8-氨基尿假设假设”,该假设假设:1)8a-瓜氨酸,
8a-瓜氨酸,8A-ino和8a-hx包括一个天然的8-氨基嘌呤系统
纳特里尔特,降压和器官保护; 2)8-氨基嘌呤缺乏症有助于盐 -
敏感的高血压,目标器官损伤和死亡率; 3)8-氨基嘌呤缺乏症可能是
通过用8-氨基嘌呤的口服治疗纠正。在这里,我们建议通过:1)进一步检验此假设
阐明8a-ino和8a-hx的肾脏效应; 2)确定高盐饮食是否诱发缺乏症
在所有4个8-氨基尿素中; 3)确定8a-ino和8a-hx,例如8a-瓜氨酸和8a-瓜氨酸,
具有降压活性并防止目标器官损伤。最后,我们将探索是否
8A-INO和8A-HX的作用机理不仅涉及PNPase的抑制,而且还涉及氧化黄氨酸的抑制作用。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWIN Kerry JACKSON其他文献
EDWIN Kerry JACKSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWIN Kerry JACKSON', 18)}}的其他基金
The Adenosinergic Pathway in Tumor-derived Exosomes
肿瘤源性外泌体中的腺苷能途径
- 批准号:
10589774 - 财政年份:2021
- 资助金额:
$ 50.96万 - 项目类别:
The Adenosinergic Pathway in Tumor-derived Exosomes
肿瘤源性外泌体中的腺苷能途径
- 批准号:
10374743 - 财政年份:2021
- 资助金额:
$ 50.96万 - 项目类别:
相似国自然基金
Slc39a13在哺乳动物铁代谢中的作用
- 批准号:32371226
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
母乳低聚糖调控动物双歧杆菌F1-7代谢芳香氨基酸机制的研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
母乳低聚糖调控动物双歧杆菌F1-7代谢芳香氨基酸机制的研究
- 批准号:32202061
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于ERα-SREBP2-HMGCR通路探讨重楼皂苷Ⅰ扰乱雌激素介导的脂质代谢致雌性动物肝毒性机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
深渊片脚类动物原位代谢测量与高质量实验技术研究
- 批准号:42276191
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
Ceramides as Novel Mediators of Tubular Metabolic Dysfunction Driving Kidney Injury
神经酰胺作为肾小管代谢功能障碍驱动肾损伤的新型调节剂
- 批准号:
10677394 - 财政年份:2023
- 资助金额:
$ 50.96万 - 项目类别:
Involvement of dopamine signaling in chronic pain-induced negative affective state and nicotine use comorbidity
多巴胺信号传导参与慢性疼痛引起的负面情感状态和尼古丁使用合并症
- 批准号:
10662951 - 财政年份:2023
- 资助金额:
$ 50.96万 - 项目类别:
Investigating the molecular mechanisms of glycosaminoglycan assembly
研究糖胺聚糖组装的分子机制
- 批准号:
10715380 - 财政年份:2023
- 资助金额:
$ 50.96万 - 项目类别:
Investigating neofunctionalized alpha-carbonic anhydrases as an emerging class of biosynthetic enzyme in plant and animal metabolism
研究新功能化α-碳酸酐酶作为植物和动物代谢中新兴的一类生物合成酶
- 批准号:
10711678 - 财政年份:2023
- 资助金额:
$ 50.96万 - 项目类别:
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
- 批准号:
10761044 - 财政年份:2023
- 资助金额:
$ 50.96万 - 项目类别: